Model-based drug development: application of modeling and simulation in drug development
Author:
Funder
Wonkwang University
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmaceutical Science
Link
http://link.springer.com/article/10.1007/s40005-017-0371-3/fulltext.html
Reference64 articles.
1. Abuhelwa AY, Mudge S, Hayes D, Upton RN, Foster DJ (2016) Population in vitro-in vivo correlation model linking gastrointestinal transit time, pH, and pharmacokinetics: itraconazole as a model drug. Pharm Res 33:1782–1794. https://doi.org/10.1007/s11095-016-1917-1
2. Almukainzi M, Gabr R, Abdelhamid G, Löbenberg R (2017) Mechanistic understanding of the effect of renal impairment on metformin oral absorption using computer simulations. J Pharm Investig 47:151–161. https://doi.org/10.1007/s40005-017-0307-y
3. Boxenbaum H (1982) Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm 10:201–227
4. Callies S, De Alwis DP, Mehta A, Burgess M, Aarons L (2004) Population pharmacokinetic model for daunorubicin and daunorubicinol coadministered with zosuquidar.3HCl (LY335979). Cancer Chemother Pharmacol 54:39–48. https://doi.org/10.1007/s00280-004-0775-4
5. Cardot JM, Davit BM (2012) In vitro–in vivo correlations: tricks and traps. AAPS J 14:491–499. https://doi.org/10.1208/s12248-012-9359-0
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm;Clinical Pharmacokinetics;2024-02-15
2. Data set of fraction unbound values in the in vitro incubations for metabolic studies for better prediction of human clearance;Database;2024
3. Mathematical modeling predicts pathways to successful implementation of combination TRAIL-producing oncolytic virus and PAC-1 to treat granulosa cell tumors of the ovary;Cancer Biology & Therapy;2023-11-27
4. Novel modeling approach integrating population pharmacokinetics and interspecies scaling to predict human pharmacokinetics of the new anti-tuberculosis agent telacebec (Q203);Biomedicine & Pharmacotherapy;2023-11
5. IMPORTANCE OF SUFFICIENT TIME POINTS FOR EFFICIENT PHARMACOKINETIC (PK) COMPARTMENTAL MODELING;International Journal of Applied Pharmaceutics;2023-01-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3